Prospective head and neck cancer research: A four-decade bibliometric perspective

Oncologist

Volumn 18, Issue 5, 2013, Pages 584-591

  Sun, Gordon H ^a,b   Houlton, Jeffrey J ^c   Moloci, Nicholas M ^a   Maceachern, Mark P ^a   Bradford, Carol R ^a   Prince, Mark E ^a   Jagsi, Reshma ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bibliometrics; Chemotherapy; Funding; Otolaryngology; Radiotherapy; Surgery

Indexed keywords

ARTICLE; BIBLIOMETRICS; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL EVALUATION; DRUG INDUSTRY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BIBLIOMETRICS; CHEMOTHERAPY; FUNDING; OTOLARYNGOLOGY; RADIOTHERAPY; SURGERY;

BIBLIOMETRICS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MEDLINE; PROSPECTIVE STUDIES; PUBLICATIONS; PUBLISHING; RESEARCH;

EID: 84878169474     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0415     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917
2. Marur S, Forastiere AA. Head and neck cancer: Changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008;83:489-501
3. Collins TR. Lecturer Warns Against Overuse of CRT: Says Many Early-Stage Laryngeal Cancer Patients Overtreated. ENT Today. Available at http://www.enttoday.org/details/article/1074133/Lecturer_Warns_Against_Overuse_of_CRT_Says_many_early-stage_laryngeal_cancer_pat.html. Accessed September 25, 2012
4. Hoffman HT, Porter K, Karnell LH, et al. Laryngealcancer in the United States: Changes in demographics, patternsofcare, and survival. Laryngoscope 2006;116:1-13
5. Moyer JS, Wolf GT, Bradford CR. Current thoughts on the role of chemotherapy and radiation in advanced head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2004;12:82-87
6. Shah JP, Karnell LH, Hoffman HT et al. Patterns of care for cancer of the larynx in the United States. Arch Otolaryngol Head Neck Surg 1997;123:475-483
7. Kim L, King T, Agulnik M. Head and neck cancer: Changing epidemiology and public health implications. Oncology(Williston Park)2010;24:915-919,924
8. Bodenheimer T. Uneasy alliance-Clinical investigators and the pharmaceutical industry. NEngl J Med 2000;342:1539-1544
9. Dorsey ER, de Roulet J, Thompson JP et al. Funding of US biomedical research, 2003-2008. JAMA 2010;303:137-143
10. Jagsi R, Sheets N, Jankovic A et al. Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research. Cancer 2009;115:2783-2791
11. Tuech JJ, Moutel G, Pessaux P et al. Disclosure of competing financial interests and role of sponsors in phase III cancer trials. Eur J Cancer 2005;41: 2237-2240
12. Booth CM, Cescon DW, Wang L et al. Evolution of the randomized controlled trial in oncology over three decades. J Clin Oncol 2008;26:5458-5464
13. Peppercorn J, Blood E, Winer E et al. Associationbetweenpharmaceutical involvementandoutcomes in breast cancer clinical trials. Cancer 2007; 109:1239-1246
14. Rose SL, Krzyzanowska MK, Joffe S. Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials. J Clin Oncol 2010;28:1316-1321
15. Sun GH, Houlton JJ, Maceachern MP etal. Influence of study sponsorship on head and neck cancer randomized trial results. HeadNeck 2012[Epubaheadof print].
16. Sullivan R, Eckhouse S, Lewison G. Using bibliometrics to inform cancer research policy and spending. In: Monitoring Financial Flows for Health Research 2007. Geneva, Switzerland: Global Forum for Health Research, 2008;67-78
17. Purushotham AD, Lewison G, Sullivan R. The state of research and development in global cancer surgery. Ann Surg 2012;255:427-432
18. Moses H 3rd, Dorsey ER, Matheson DH et al. Financial anatomy of biomedical research. JAMA 2005;294:1333-1342
19. Bland KI. Concerning trends and outcomes for National Institutes of Health funding of cancer research. J Surg Oncol 2007;95:161-166
20. Higgins KM, Wang JR. State of head and neck surgical oncology research-A review and critical appraisal of landmark studies. Head Neck 2008;30: 1636-1642
21. Horton R. Surgical research or comic opera: Questions, butfewanswers. Lancet 1996; 347:984-985
22. Rangel SJ, Efron B, Moss RL. Recent trends in National Institutes of Health funding of surgical research. Ann Surg 2002;236:277-286; discussion 286-287
23. Cambrosio A, Keating P, Mercier S et al. Mapping theemergenceanddevelopmentof translational cancer research. Eur J Cancer 2006;42:3140-3148
24. Lewison G, Purushotham A, Mason M et al. Understanding the impact of public policy on cancer research: A bibliometric approach. Eur J Cancer 2010;46:912-919
25. Marshall JL. Philanthropy, advocacy and colon cancer. Clin Colorectal Cancer 2011;10:290
26. Committee on the Public Health Effectiveness of theFDA510(k) Clearance Process, Institute of Medicine. Medical Devicesandthe Public's Health:TheFDA510(k) Clearance Process at 35 Years. Washington, DC: The NationalAcademiesPress, 2011
27. GAO-09-190. Medical Devices: FDA Should Take Steps to Ensure that High-Risk Device Types Are Approved Through the Most Stringent Premarket Review Process. Washington, DC: Government Accountability Office, 2009
28. Meropol NJ, Schulman KA. Cost of cancer care: Issuesandimplications. J ClinOncol2007;25:180-186
29. Mann M, Tendulkar A, Birger N et al. National Institutes of Health funding for surgical research. Ann Surg 2008;247:217-221
30. Jagsi R, Guancial EA, Worobey CC et al. The "gender gap" in authorship of academic medical literature- a 35-year perspective. NEngl JMed 2006; 355:281-287
31. Angell M, Utiger RD, Wood AJ. Disclosure of authors' conflicts of interest: A follow-up. N Engl J Med 2000;342:586-587
32. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: Editorial practices and author disclosures. Sci Eng Ethics 2001;7:205-218
33. Slim K. Limits of evidence-based surgery. World J Surg 2005;29:606-609.